ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
6
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,781
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
ODM-207, a novel BET-bromodomain inhibitor as a therapeutic approach for the treatment of patients with castration resistant prostate cancer
Author(s):
M BJORKMAN
,
E Mattila
,
R Riikonen
,
C Sekhar
,
M. Jaleel
,
S Marappan
,
T. Ikonen
,
D Nicorici
,
S. Samajdar
,
M. Ramachandra
Publication date:
2016
Journal:
Eur. J. Cancer
Read this article at
ScienceOpen
Publisher
Further versions
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
cGMP: Generators, Effectors and Therapeutic Implications Conference
Author and article information
Journal
DOI::
10.1016/S0959-8049(16)32863-5
Data availability:
Comments
Comment on this article
Sign in to comment
Related Documents Log
scite_
Similar content
2,781
Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies
Authors:
De los ODM a los ODS
Authors:
Fondo ODS
Nitrogen certificates for 417,000 tons granted by ODM to 13 chemical companies
Authors:
See all similar
Cited by
1
AR Splicing Variants and Resistance to AR Targeting Agents
Authors:
Mayuko Kanayama
,
Changxue Lu
,
Jun Luo
…
See all cited by